Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas—a randomized controlled trial (PRIMA)

<strong>Background</strong> Plasmodium vivax forms dormant liver stages that can reactivate weeks or months following an acute infection. Recurrent infections are often associated with a febrile illness and can cause a cumulative risk of severe anaemia, direct and indirect mortality, and...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Thriemer, K, Degaga, TS, Christian, M, Alam, MS, Ley, B, Hossain, MS, Kibria, MG, Tego, TT, Abate, DT, Weston, S, Karahalios, A, Rajasekhar, M, Simpson, JA, Rumaseb, A, Mnjala, H, Lee, G, Anose, RT, Kidane, FG, Woyessa, A, Baird, K, Sutanto, I, Hailu, A, Price, RN
Formato:	Journal article
Idioma:	English
Publicado em:	BioMed Central 2022

Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas—a randomized controlled trial (PRIMA)

Registos relacionados